TRCT
CMND icon

Tower Research Capital (TRC)’s Clearmind Medicine CMND Stock Holding History

Tower Research Capital (TRC)’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$1.29K – 5270
2024
Q4 		$1.29K Buy
+2
New +$1.11K ﹤0.01% 5054
2023
Q3 		– Hold
0
– -$1.94K – 5980
2023
Q2 		– Hold
0
– – – 5293
2023
Q1 		– Hold
0
– – – 4942

Other funds holding CMND

GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Tower Research Capital (TRC)'s CMND Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Clearmind Medicine (CMND) in Q1 2025, closing a stake of 2 shares — an estimated $1.29K sold.

Tower Research Capital (TRC) first reported a position in CMND in Q4 2024 and held it in 1 quarter. The position peaked at $1.29K in Q4 2024. 7 funds tracked by Wall St. Rank hold CMND as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Clearmind Medicine position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2 Clearmind Medicine shares in Q1 2025, an estimated $1.29K.
  • Tower Research Capital (TRC) first reported a position in Clearmind Medicine in Q4 2024 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Clearmind Medicine position peaked at $1.29K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Clearmind Medicine as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.